Takeda Competitors and Similar CompaniesClear all
Takeda's competitors and similar companies include Nipro, Grifols, Codiak Biosciences, Amgen, Novartis, GSK and Pfizer.
 Takeda Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Nipro Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ||
Founding Date | Founding Date 1781 | Founding Date 1954 | Founding Date 1909 | Founding Date 2015 | Founding Date 1980 | Founding Date 1996 | Founding Date 2000 | Founding Date 1849 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||||
Locations | Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more | Locations Cambridge, US HQ | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Brentford, GB HQ Boumerdes, DZ San Fernando, AR Abbotsford, AU Boronia, AU Ermington, AU Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | ||
Employees | Employees 49,281 | Employees 38,117 | Employees 23,0002% decrease | Employees 1023% decrease | Employees 25,200 | Employees 76,057 | Employees 70,212 | Employees 83,0005% increase |
Valuation ($) | Valuation ($) 43.7 b | Valuation ($) 1.5 b | Valuation ($) 6.7 b | Valuation ($) 2.8 m | Valuation ($) 170.4 b | Valuation ($) N/A | Valuation ($) 862.5 m | Valuation ($) 163.9 b |
Financial | ||||||||
Revenue (est.) | Revenue (est.) ¥4.3t (FY, 2024) | Revenue (est.) ¥586.8b (FY, 2024) | Revenue (est.) €6.6b (FY, 2023) | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) $28.2b (FY, 2023) | Revenue (est.) $54.1b (FY, 2023) | Revenue (est.) £30.3b (FY, 2023) | Revenue (est.) $58.5b (FY, 2023) |
Cost of goods | Cost of goods ¥698.7b (FY, 2024) | Cost of goods ¥356.6b (FY, 2024) | Cost of goods €3.7b (FY, 2023) | Cost of goods N/A | Cost of goods $8.5b (FY, 2023) | Cost of goods $8.2b (FY, 2023) | Cost of goods £5.8b (FY, 2023) | Cost of goods $25b (FY, 2023) |
Gross profit | Gross profit ¥3.6t (FY, 2024) | Gross profit ¥230.2b (FY, 2024) | Gross profit €2.9b (FY, 2023) | Gross profit N/A | Gross profit $19.7b (FY, 2023) | Gross profit $47.7b (FY, 2023) | Gross profit £25.7b (FY, 2023) | Gross profit $33.5b (FY, 2023) |
Net income | Net income ¥144.2b (FY, 2024) | Net income ¥12.2b (FY, 2024) | Net income €180.7m (FY, 2023) | Net income ($37.2m) (FY, 2021) | Net income $6.7b (FY, 2023) | Net income $9b (FY, 2023) | Net income £5.3b (FY, 2023) | Net income $2.2b (FY, 2023) |
Operating ⚠ | ||||||||
Countries | Countries N/A | Countries N/A | Countries 110 (H2, 2021) | Countries N/A | Countries 100 (FY, 2020) | Countries N/A | Countries 92 (FY, 2021) | Countries 125 (FY, 2021) |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products 16 (FY, 2021) | Phase I Trials Products 27 (FY, 2021) |
Phase I/II Trials Products (Oncology) | Phase I/II Trials Products (Oncology) 13 (Jul, 2023) | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) 49 (FY, 2021) | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 2 (Q2, 2020) | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products 25 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products 27 (FY, 2021) |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) 6 (Jul, 2023) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 27 (FY, 2021) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A | Registration Phase Products 10 (FY, 2021) |
Funding | ||||||||
Total funding raised | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 168.5m | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Nipro
HQ
Settsu, JP
Employees
38,117
Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business.
View company
Grifols
HQ
Sant Cugat del Vallès, ES
Employees
23,000↓ 2% decrease
Grifols is a pharmaceutical and chemical manufacturer.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
102↓ 3% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companyAmgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company